Ultraearly treatment on sudden deafness and the... (2002 study) Skip to main content
Clinical Study Zhonghua er bi yan hou ke za zhi 2002

Ultraearly treatment on sudden deafness and the influence on superoxide dismutase and malonyldialdehyde of serum.

Wang W, Xu R, Yao M, Zhonghua er bi yan hou ke za zhi, 2002

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers in China compared hearing results in people with sudden deafness who started treatment at different times, and measured two blood markers (SOD and MDA) at the same time.

What They Found

In a clinical study of 147 people with sudden deafness (168 ears) who all received medicine plus hyperbaric oxygen, those treated within 6 hours had a statistically significant greater improvement in hearing than those treated within 15 days or after 15 days (both p less than 0.01). In the group treated within 6 hours (36 ears), hearing returned to normal in 18 ears, improved significantly in 9, improved in 7 and did not change in 2. In the group treated within 15 days (63 ears), hearing returned to normal in 11 ears, improved significantly in 16, improved in 15 and did not change in 21. In the group treated after 15 days (69 ears), hearing returned to normal in 14 ears, improved significantly in 20, improved in 13 and did not change in 22. The two later groups did not differ significantly from each other (p greater than 0.01). The abstract also says 30 healthy volunteers served as a control group for the blood markers.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

The abstract describes groups divided by treatment timing with no comparison group that skipped hyperbaric oxygen, so it cannot show what hyperbaric oxygen contributed, and it does not report hyperbaric protocol details such as pressure or number of sessions.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Clinical Study
Category Uncategorised
Source Pubmed
PubMed ID 12772413
Year Published 2002
Journal Zhonghua er bi yan hou ke za zhi
MeSH Terms Adult; Combined Modality Therapy; Female; Hearing Loss, Sudden; Humans; Hyperbaric Oxygenation; Male; Malondialdehyde; Middle Aged; Nimodipine; Superoxide Dismutase

Cite This Study

Share

Find a Canadian Clinic Treating Uncategorised

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: April 1, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology